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Objective:  Pathomechanisms  of  sedentary  behaviour  (SB)  are unclear.  We  conducted  a systematic  review
to investigate  the associations  between  SB  and  various  biomarkers  in  older  adults.
Methods: Electronic  databases  were  searched  (MEDLINE,  EMBASE,  CINAHL,  AMED)  up  to July  2015  to
identify  studies  with  objective  or  subjective  measures  of  SB, sample  size  ≥50,  mean  age  ≥60  years  and
accelerometer  wear  time  ≥3  days.  Methodological  quality  was  appraised  with  the  CASP  tool.  The  protocol
was pre-speciﬁed  (PROSPERO  CRD42015023731).
Results:  12701  abstracts  were  retrieved,  275  full  text  articles  further  explored,  from  which  249 were
excluded.  In the ﬁnal  sample  (26 articles)  a total  of  63 biomarkers  were  detected.  Most  investigated
markers  were:  body  mass  index  (BMI,  n  = 15),  waist  circumference  (WC,  n =  15),  blood  pressure  (n  = 11),
triglycerides  (n = 12)  and high  density  lipoprotein  (HDL,  n  =  15).  Some  inﬂammation  markers  were  iden-
tiﬁed  such  as interleukin-6,  C-reactive  protein  or tumor  necrosis  factor  alpha.  There  was  a  lack  of  renal,
muscle  or  bone  biomarkers.  Randomized  controlled  trials found  a positive  correlation  for  SB  with  BMI,
neck circumference,  fat  mass,  HbA1C,  cholesterol  and  insulin  levels,  cohort  studies  additionally  for WC,
leptin,  C-peptide,  ApoA1  and  Low  density  lipoprotein  and  a negative  correlation  for  HDL.
Conclusion:  Most  studied  biomarkers  associated  with  SB  were  of cardiovascular  or metabolic  origin.  There
is a  suggestion  of a negative  impact  of  SB  on biomarkers  but still  a paucity  of high  quality  investi-
gations exist.  Longitudinal  studies  with  objectively  measured  SB  are needed  to further  elucidate  the
pathophysiological  pathways  and  possible  associations  of  unexplored  biomarkers.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
According to the National Institute of Health (NIH) Biomark-
ers Deﬁnitions Working group (Biomarkers Deﬁnitions Working
Group, 2001), a biomarker is a characteristic that is objectively mea-
sured as an indicator of normal biological processes, pathogenic
processes, or a pharmacological response to a therapeutic inter-
vention. Therefore, biomarkers can be very helpful as surrogate
markers for diseases or pathophysiological links between exposure
and disease; or as intermediate measures of the effectiveness of
interventions on disease processes. Within the past few decades,
a considerable amount of literature has clearly demonstrated that
physical activity (PA) has a range of beneﬁts on the health (Nelson
et al., 2007; Castaneda et al., 2002) and wellbeing of older adults
(McAuley et al., 2000). Recently, there has been an interest in
understanding the biomarkers underlying the response to PA. For
example, in a cohort of community dwelling older adults, lev-
els of N-terminal pro-brain natriuretic peptide (NT-proBNP) and
high-sensitive troponin T have been associated with objectively
monitored PA and showed a more beneﬁcial proﬁle with increas-
ing PA, suggesting a dose response relationship (Jefferis et al., 2014;
Klenk et al., 2013). To date, most of the PA biomarker research has
focussed on cardiovascular risk factors (Gabriel et al., 2012; Reaven
et al., 1991; Jefferis et al., 2014), but there are many other biological
systems with associated biomarkers which may  be affected by PA or
especially SB. Recent examples include -amyloid burden and glu-
cose metabolism as markers of neurodegeneration (Okonkwo et al.,
2014), interleukin-6 (IL-6) and C-reactive protein (CRP) as markers
for systemic inﬂammation (Jarvie et al., 2014) or DNA-repair as a
marker for cell homeostasis (Brocklebank et al., 2015).
An emerging evidence base has started to demonstrate that
sedentary behaviour (SB), over and above time spent in PA, is inde-
pendently associated with several important detrimental health
outcomes, including endpoints such as mortality, frailty, sarcope-
nia, dementia, and cardiovascular diseases (Biswas et al., 2015).
According to the Sedentary Behaviour Research Network, SB is
deﬁned as any waking behaviour characterised by an energy expen-
diture ≤1.5 metabolic equivalents (METs) whilst in a sitting or
reclining posture (Sedentary Behaviour Research Network, 2012).
The emerging research highlighting the deleterious impact of SB on
health is of particular concerns as adults spend on average 5 h of
their time in sedentary behaviour (Loyen et al., 2016). Indeed, some
studies have demonstrated that on the population-level sedentary
time (ST) increased over the decades from 1960 to 2010 (Church
et al., 2011). Especially older people spent most of their time in SB.
A recent meta-analysis illustrated that older people were seden-
tary for 65–80% of their waking time (Wullems et al., 2016), other
sources mentioned ST with an average of 9 h (Dunlop et al., 2015)
to 13.8 h per day (Cawthon et al., 2013). Older people are seen
as the age group engaging in the highest level of SB (Wullems
et al., 2016) and thus could beneﬁt most from changing their daily
habits. The developing evidence on the harms associated with SB
has illustrated that it is not only the absence of daily or weekly
moderate-to-vigorous physical activity (MVPA), but rather, SB is
a separate category of behaviour with unique determinants, con-
sequences and sequences for possible intervention (Owen et al.,
2010). Considering the physiological changes occurring with age in
several organ systems (Boss and Seegmiller, 1981), results from
middle-aged adults can’t be simply transferred to older adults.
Therefor the EU study SITLESS investigates how SB can be reduced
sustainably and how sedentariness effects biomarkers especially in
older adults. In this framework the interest on outcomes of studies
performed in elderly, assessing SB and its impact on biomarkers
was the focus. In addition, biomarker studies are important to
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further understand the link between SB, PA and adverse health out-
comes like total mortality and harmful phenotypes like Metabolic
Syndrome (MES) (Gardiner et al., 2011), frailty or sarcopenia. Per-
haps it can help to understand the role of biomarkers as possible
mediators of the association between SB and adverse phenotypes
or aging-related diseases. Therefore, the aims of this systematic
review were to provide a comprehensive overview of aging-related
biomarkers associated with SB and report on the strength of the
observed associations in community-dwelling older adults.
2. Methods
2.1. Study design
This systematic review adhered to the PRISMA guidelines
(Moher et al., 2009) and followed a predetermined published pro-
tocol (PROSPERO No. CRD42015023731) (Stubbs et al., 2015).
2.2. Condition or domain being studied
SB, as deﬁned by the Sedentary Behaviour Research Network
(2012) (waking behaviour with an energy expenditure ≤ 1.5 METs
whilst in a sitting or reclining posture), represented our exposure
of interest. We  also considered studies which did not fully com-
ply with this deﬁnition (e.g. television watching time, SB identiﬁed
by other questionnaires or accelerometer data that do not allow
for disentangling posture issues or clearly indicate METs) but are
highly relevant to SB.
With respect to the biomarkers we were interested in any
inﬂammatory, renal and cardiac biomarkers, lipids and metabolic
markers, genetic and metabolomics markers, endocrine markers
and markers of muscle strength, body composition, as well as of
speciﬁc physical performance measures (e.g. gait speed and bal-
ance).
2.3. Information sources and searches
Two authors (KW, BS) searched the electronic databases:
MEDLINE (PubMed), EMBASE, CINAHL (via EBSCO), AMED (via
Ovid/EBSCO) from inception to 15 July 2015. We  used search terms
described in Appendix A. Appropriate search strategies and MESH-
terms were selected (see Appendix A).
2.4. Study selection and eligibility criteria
Studies meeting the following criteria were included:
a Explicitly measured SB using objective accelerometer wear
time ≥ 3 days (to follow the recommendations of good clinical
practice (Ward et al., 2005)) or self-report instruments. Studies
deﬁning SB purely as a lack of PA were excluded.
b Including community dwelling, older adults (mean age of sam-
ple ≥ 60 years).
c Sample size of n ≥ 50 participants, to ensure adequate power.
d Quantitative study design including randomized controlled
trials (RCTs), controlled clinical trials (CCTs), pre- and post-
intervention measurement studies, prospective observational
studies (POS), or studies (only prospective trials) that examined
an association of any biomarker with SB. We  also consid-
ered cross-sectional studies (CSS) but present them separately
because of their descriptive nature due to the inability to clearly
establish the temporal sequence between SB and biomarkers.
2.5. Participants and population
We selected studies, with the above mentioned characteristics
that included older adults (mean age ≥ 60 years) conducted in the
community.
When we  encountered studies with a large age range and a mean
age below 60 years, indicating the study included some older adults
(>60 years), we  attempted to contact the authors to acquire the
variables of interest for all participants with an age of 60 years and
older. Populations with speciﬁc co-morbidity (e.g. diabetes mellitus
type 2 (DM-II)), peripheral artery disease (PAD), chronic obstructive
pulmonary disease (COPD) were included, but critically evaluated
and highlighted as such.
2.6. Data extraction
All results of the searches were inserted in a bibliographic
database. A data extraction form was  created and amended to the
requirements of the review. Two authors piloted (KW; SB) the data
extraction form in a random sample of 3 studies that employ differ-
ent study designs. This ensured that the relevant information was
selected to assess the effectiveness and study quality.
All data were extracted by these two  reviewers. Data extrac-
tion included: ﬁrst author, country, setting, population, aims of
the study, type of the study (RCT, POS or CSS), number of studies
and participants included in the article, details of the intervention
(including duration), inclusion criteria, type of recruitment, type
and deﬁnition of SB or PA used, biomarkers analysed and results,
details of control condition, overall study quality (internal risk of
bias), association statistics, acknowledged limitations by authors,
the authors’ conclusions and other notes.
Any disagreements in data extraction were resolved through
discussion between the reviewers.
2.7. Risk of bias and quality assessment
Assessment of studies followed the PRISMA (Moher et al., 2009)
guidelines. Two authors conducted the methodological quality
appraisal of all included studies using a modiﬁed Critical Appraisal
Skills Programme (CASP) tool, adapted for each study design (CASP,
2016):
• RCTs (max. CASP score = 6) were assessed for risk of bias in the
following domains: clearly focused issue, randomization, perfor-
mance (blinding, personnel), comparability (treatment, groups at
baseline) and attrition (participants accounted for at its conclu-
sion).
• POS (max. CASP score = 8) were assessed for risk of bias in the fol-
lowing domains: clearly focused issue, selection and recruitment
(random approach or representative for a deﬁned population,
accuracy of measurement (exposure, outcome), identiﬁcation of
important confounding factors, adjustment for confounding fac-
tors and follow-up (period, completion).
• CCS (max. CASP score = 6) were assessed for risk of bias in: clearly
focused issue, selection and recruitment (random approach or
representative for deﬁned population), accuracy of measurement
(exposure, outcome), identiﬁcation of important confounding
factors and adjustment for confounding factors.
In an attempt to assess the potential effect and direction of the
effect of SB on speciﬁc biomarkers, additional information related
to statistical evidence of an association, as adapted from the Cana-
dian Agency for Drugs and Technology in Health (CADTH) (CADTH,
2016), was included in Table 2 for the high quality studies. The fol-
90
 
K
.
 W
irth
 et
 al.
 /
 A
geing
 R
esearch
 R
eview
s
 35
 (2017)
 87–111
Table 1a
Descriptive overview of randomized controlled trials (RCTs) and prospective observational studies (POS).
Author, Year,
Country
Setting, country, study Follow-up No. of participants male Age, mean ±SD
[years]
sedentary behaviour
assessment (method:
measure)
measured biomarkers CASP score remarks
RCTs Kallings et al.
(2009), Sweden
CD, “Move study”, efﬁcacy of
PA on prescription to reduce
CMRF
6  months CG: 54 IG: 47 43%
43%
all 68 years IPAQ questionnaire:
total sitting time in
hours/day
BMI, WC,  AD, NC, BF%, fat
mass, BF% in trunk, fat
mass in trunk, glucose,
HbA1c, s/d BP, cholesterol,
HDL, LDL, LDL/HDL,
triglycerides, ApoA1, ApoB,
ApoB/ApoA1
5  of 6
Kirk et al. (2009),
UK
CD + RP,“Time2Act study“ in
DM-II patients, compare 2
methods of PA promotion to
standard care
6 & 12 months CG: 35 IG1: 47 IG2:
52
51%
53%
42%
59.2 ± 10.4
60.9 ± 9.6
63.2 ± 10.6
ActiGraph GT1M (waist)
for 7 days (≥10 h/d and
≥4days), SB not deﬁned
BMI, WC,  s/d BP,
cholesterol, HDL, HbA1c
4  of 6 Groups were
not equally
balanced
Suboc et al. (2014),
USA
CD, investigate if reduction of
SB improves vascular
endothelial function and
speciﬁc biomarkers
12 weeks CG: 35
IG1: 32 IG2: 29
76%
61%
60%
62 ± 7
64 ± 7
63 ± 8
ActiGraph GT3X for 7 days,
(≥600 min/d and ≥4 days):
SB deﬁned as ≤ 1.5 METS
or <100 counts/min
BMI, WC,  glucose, insulin,
QUICKI, HOMA-IR,
cholesterol, HDL, LDL,
triglycerides, CRP, s/d BP,
HR, brachial artery
diameter, peak shear,
hyperemic peak shear,
Nitroglycerin mediated
dilation, carotid-femoral
pulse wave velocity,
augmentation index, aortic
s/d BP
6 of 6
Aadahl et al.
(2014), Denmark
CD, Health2010 study, effect of
motivational counseling at
reducing sitting time
6 months total: 66 CG: 28 IG:
38
nr 63
IG: 64.1
CG: 63.8
ActivPAL 3TM (triaxial,
right thigh) for 7 days (at
least 2 days for analysis),
SB not deﬁned
WC,  BF%, glucose, insulin,
HbA1c, cholesterol, HDL,
LDL, triglycerides
5 of 6 Only 2 days of
accelerometer
but 94% of total
group n = 166
had 5 days or
more; special
sub-analysis
for us with
peo-
ple > 60 years;
POS  Fung (2000), USA CD, “Health Professionals
Follow-up Study”, television
watching and biomarkers
1986–1994 466 100% 60 Questionnaire: hours of
television watching/week
BMI, cholesterol, HDL, LDL,
triglycerides, ApoA1, Lp(a),
Leptin Fibrinogen, Insulin,
C-peptide, HbA1c
5 of 8 Biomarker only
at
follow-up → no
change
available
Cooper et al.
(2012), UK
CD + RP, “Early ACTivity in
Diabetes study”, with DM-II
patients, RCT but results
treated as a cohort
6 months 528 cross
sectional; 380
longitudinal data
65% 59.8 ± 10.0 ActiGraph GT1M (waist)
for 7 days (≥600 min/d and
≥3 valid days) removed for
sleeping; non-wear time
≥20 min with 0 counts, SB
(h/day) deﬁned as <100
counts/minute
WC,  HbA1c, HDL, glucose,
insulin, HOMA-IR
5 of 8
AD = abdominal diameter; Apo = Apo lipoprotein; BF% = percent of body fat; BMI  = body mass index; BP = blood pressure; CD = community-dwelling; CG = control group; CMRF = cardio-metabolic risk factors; CRP = C-reactive
protein;  DM-II = diabetes mellitus type 2; HbA1c = glycated hemoglobin; HDL = high density lipoprotein; HOMA-IR = homeostatic model assessment of insulin resistance; HOMA%B = homeostatic model assessment of B-cell function;
HR  = heart rate; IG = intervention group; MET = metabolic equivalent; LDL = low density lipoprotein; Lp(a) = lipoprotein a; NC = neck circumference; nr = not reported; s/d BP = systolic/diastolic blood pressure; PAS = physical activity
scale;  POS = prospective observational studies; QUICKI = quantitative insulin sensitivity check index; RCT = randomized controlled trials; RP = risk population; WC = waist circumference.
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Fig. 1. Flow chart for article selection of randomized controlled trials (RCT), prospective observational studies (POS) and cross-sectional studies (CSS).
*Remark: One study of Cooper et al. (2012) was  a cohort study with prospective data as well as cross sectional data and thus counted as POS and CS.
lowing decision rules as suggested by CADTH (CADTH, 2016), were
used for standardised statements about the statistical signiﬁcance:
• 0% of studies showed statistically signiﬁcant results = no evidence
for any association
• 1% to 33% of studies showed statistically signiﬁcant
results = generally no evidence for any association.
• 34% to 66% of studies showed statistically signiﬁcant
results = mixed evidence for association
• 67% or more studies showed statistically signiﬁcant
results = generally evidence for association
Due to the few studies of high quality, we decided to apply this
method of categorisation, although often less than 5 studies with
statistically signiﬁcant results were found. To ensure a minimum
level of validity, we applied this tool in all biomarkers measured in
≥3 studies (RCT and/or POS).
2.8. Strategy for data synthesis and subgroup analysis
We tabulated the single study results and grouped them accord-
ing to comparable biomarkers. All results were stratiﬁed with
appropriate subgroup analyses, for instance according to expo-
sure type (SB and PA separately), type of SB/PA assessment
(questionnaire- versus sensor-based), biomarker type and study
design (RCT and CCT separately). We  anticipated conducting a
meta-analysis if sufﬁcient homogeneity was evident across the
study types and outcomes of interest and enough studies could be
identiﬁed in comparable areas.
3. Results
3.1. Results of the literature search
Our initial searches identiﬁed 12,701 hits. After the exclusion at
title level, removing of duplicates and the matching of results from
the two  independent reviewers (including removing duplicates), a
ﬁnal list of 275 full-text articles was  scrutinised. 235 articles were
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subsequently excluded according to our in- and exclusion crite-
ria (full details in Fig. 1). 3 studies included people with a large
age range in their sample, yet a mean age below 60 years. Upon 3
attempts to contact the authors, 1 group (Aadahl et al., 2014)) pro-
vided additional data, whilst 2 authors did not respond and were
subsequently excluded due to age <60 years (Knight et al., 2014;
Mohri et al., 2013).
After exclusions, 40 studies were considered eligible, however
after further revision and evaluation, another 14 articles (1 POS,
13 CSS) were excluded (for more details see “risk of bias (quality)
appraisal”), thus leading to a total of 26 articles (4 RCT, 2 POS and
21 CSS). The study from Cooper et al. (2012) was included as a POS
and CSS due to longitudinal and cross-sectional analysis of the data
reported by the study authors.
3.2. Deﬁnition of sedentary behaviour
We  found a highly heterogeneous deﬁnition of SB, which was
often misclassiﬁed as simply the absence of PA and therefor 134
papers were excluded. The most frequent deﬁnition of SB was total
time spent at less than 100 counts per minute using data from an
accelerometer (Gabriel et al., 2012; Cooper et al., 2012; Bann et al.,
2015; Gennuso et al., 2013; Lee et al., 2015; Lynch et al., 2010, 2011;
Santos et al., 2012; Sardinha et al., 2015; Stamatakis et al., 2012).
Henson et al. (2013) deﬁned SB in a similar way but with smaller
epochs of less than 25 counts per 15 s. Other authors used the same
deﬁnition of SB as used in this review with less than 1.5 MET  (Bann
et al., 2015; Cooper et al., 2014; Suboc et al., 2014). Some studies
did not deﬁne SB at all (Aadahl et al., 2014; Kirk et al., 2009).
A total of 14 studies (3 RCT, 1 POS, 11 CSS, whereas Cooper et al.
(2012) were included as POS and CSS) measured SB with sensors
or accelerometers, another 2 CSS (Bann et al., 2015; Stamatakis
et al., 2012) with both, accelerometer and questionnaire, while 10
studies measured SB by questionnaires only. Of these 10 question-
naires, 6 enquired about TV watching time (1 POS, 5 CSS), whilst
the remainders included more detailed questions about SB (1 RCT,
3 CSS).
3.3. Characteristics of included studies
3.3.1. Randomized controlled trials (RCTs)
An overview of the RCTs is listed in Table 1a. Overall, a total of
397 participants in the RCTs were represented (Intervention Group,
(IG): 245; Control Group, (CG): 152). Although SB was  evaluated,
the primary aims of 2 RCTs were to increase PA but not reduce SB. 3
RCTs (Aadahl et al., 2014; Suboc et al., 2014; Ewald et al., 2010) cap-
tured SB objectively with an accelerometer (ActiGraph), whereas
Kallings et al. (2009) evaluated SB with the International Physical
Activity Questionnaire (IPAQ), which consists of 2 questions on the
amount of sitting time in the last 7 days; one for average weekday
and one for average weekend day.
Intervention was mainly focused on increasing habitual PA. This
was triggered through different processes: an intervention with
pedometer-use plus a weekly visit on an interactive website with
the aim of increasing PA level by 10% each week up to 10,000
steps/day (Suboc et al., 2014); written PA prescription with the
aim of increasing PA level to 30 min  MVPA per day (Kallings et al.,
2009); a written PA pack with a self-instructional workbook based
on a trans-theoretical model of behaviour change (Kirk et al., 2009).
Only 1 study focused on decreasing SB with 4 main aims, such as
decreasing daily TV viewing time, substitute sitting with standing,
break up prolonged sitting time and a maximum of 30 min  of sitting
per episode (Aadahl et al., 2014).
3.3.2. Prospective observational studies (POS)
An overview of the POS is listed in Table 1a. In the 2 cohort
studies (Cooper et al., 2012; Fung, 2000) a total of 846 participants
were represented. Fung (2000) used a questionnaire focusing on
the number of hours of television watching to measure SB in men,
whereas Cooper et al. (2012) used objectively measured SB time by
accelerometer measurements (ActiGraph).
3.3.3. Cross-sectional studies (CSS)
A total of 41,816 participants were included across the 21 CSS.
The characteristics of these CCS are listed in Table 1b. Most of
the studies focused on SB and its association to biomarkers (16/21
studies), from which 5 focused on TV watching time. 2 other stud-
ies investigated both SB and PA as exposure (Lynch et al., 2010;
Santos et al., 2012), 1 study (Larsen et al., 2014a) calculated sit-
ting time, whereas 2 studies evaluated SB as secondary outcome
(Gabriel et al., 2012; Reaven et al., 1991).
The majority of the studies used objectively measured time of SB
by accelerometer (11/21 studies). 2 studies evaluated both objec-
tively measured SB and SB measured by questionnaire (Bann et al.,
2015; Stamatakis et al., 2012). 5 studies focused on time spent with
TV watching and 3 used the following questionnaires: Reaven et al.
(1991) adapted a questionnaire from the Health Interview Survey,
which measured 17 different leisure time activities in the last 2
weeks; Larsen et al. (2014a) measured daily SB by asking about
time spent being sedentary on a typical weekday; Allison et al.
(2012) evaluated the time spent being sedentary by using the “Typ-
ical Week Physical Activity Survey” which measures SB in the last
7 days.
3.4. Sedentary behaviour and biomarkers
3.4.1. Overview of biomarkers explored in the literature
Table 2 provides an overview of the associations between SB and
each biomarker system including: anthropometric parameters, sys-
temic parameters, blood lipids, glycaemic parameters, performance
biomarkers, inﬂammatory biomarkers and others. A total of 63
biomarkers were evaluated (counting ratios of different biomarkers
separately). Table 3 considers the speciﬁc biomarker results within
each study design. There was insufﬁcient homogenous data to per-
form a meta-analysis. Therefore, we describe the number of studies
that explored each biomarker and the summary statistics report-
ing the overall proportion of these studies that found a statistical
association. Only the statistically signiﬁcant results from the mul-
tivariable analyses are shown. If signiﬁcant, biomarkers showed
evidence for an unfavourable association with higher ST. Body mass
index (BMI, 9 of 15 of the studies signiﬁcant), waist circumference
(WC, more than 8 of 15 of the studies signiﬁcant), insulin (4 of
8 studies signiﬁcant) and high density lipoprotein (HDL, 6 of 15
studies signiﬁcant) were examined in a lot of studies and demon-
strated the most reliable results. For a more detailed description
see Tables 2 and 3.
We  identiﬁed 4 “risk population” studies. 1 POS of Cooper et al.
(2012), performed in diabetes type 2 patients, showed a (statisti-
cally signiﬁcant) positive correlation for SB with WC,  HDL, insulin
and HOMA-IR. The CSS from Cooper et al. (2014), also performed in
diabetes type 2 patients, revealed a positive association for SB with
WC,  too. The study from Lee et al. (2015), performed in the high
risk osteoarthritis population showed lower gait speed and lower
chair stand rate associated with higher levels of SB. There were no
statistically signiﬁcant results for the study of Lynch et al. (2010)
investigating the association between SB with BMI, WC and insulin
in a breast cancer survivor cohort.
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Table 1b
Descriptive overview of 21 cross-sectional studies (CSS).
Author, year,
country
Setting, study, aim No. of
partici-
pants
Male
(%)
Age, mean
(±SD/range)
[years]
Sedentary behaviour (SB)
assessment (method: measure)
Analyzed
biomarkers
CASP
score
Remarks
Allison et al.
(2012), USA
CD, Multi-Ethnic Study of
Atherosclerosis (MESA),
association of SB with
adiposity associated measures
of inﬂammation
1543 49.8 64.3 (9.6) (45–84) Questionnaire “Typical Week
Physical Activity Survey” (TWPAS),
which measures also SB (TV,
computer, reading) (min/week:
continuous and in tertiles) during a
typical week
adiponectin, leptin,
TNF-a, resistin,
adiponectin/leptin
4 of 6 Multivariate adjusted means
and coefﬁcients of multivariate
linear regression models, three
models with different level of
adjustment;
Anuradha et al.
(2011), USA
McAuley et al.
(2000)
CD, Multi-Ethnic Study of
Atherosclerosis (MESA),
association of TV watching
time and retinal vascular
caliber
5893 48 63.1 (9.9) (45–84) Questionnaire about TV watching
time (quartiles: hours/week)
during a typical week
central retinal
artery equivalent,
central retinal vein
equivalent
4 of 6 Least square means of
multivariate linear regression
models, two models with
different level of adjustment
Bankoski et al.
(2011), USA
CD, National Examination
Survey (NHANES); association
between SB and MES
1367 51.8 71 (7.8) (≥60) ActiGraph AM-7164 (uniaxial,
waist) for 7 days (≥4 valid days)
removed for bathing and sleeping;
non-wear time >60 min  with 0
counts; SB (hours/day) deﬁned as
<100 counts/minute
dichotomized: WC,
HDL, triglycerides,
glucose, BP
5 of 6 Means adjusted for age and sex
Bann et al. (2015),
USA
CD, Lifestyle Interventions and
Independence for Elders (LIFE)
Study, association of SB with
BMI  and grip strength
1130 33 NR (70–89)
m: 79.3 (5.3)
w: 78.5 (5.3)
ActiGraph GT3X (triaxial, waist) for
7  days (≥600 min/d and ≥3 valid
days) removed for bathing and
sleeping; non-wear time ≥90 min
with 0 counts; SB (min/day)
deﬁned as <100 counts/minute
CHAMPS questionnaire about a
typical week; SB (min/day) was
deﬁned as time ≤1.5 METs
BMI, grip strength 4 of 6 Coefﬁcients of multivariate
linear regression models, two
models with different level of
adjustment; no numbers
regarding men  and women
although all analyses were
stratiﬁed according to sex
Cooper et al.
(2012), UK
RP (type 2 diabetes), Early
Activity in Diabetes
(Early-ACTID), association
between SB & CMRF
528
m: 344
w:  184
65 59.8 (10) (30–80)
m:  60.7 (9.7)
w: 58.1 (10.4)
ActiGraph GT1M (waist) for 7 days
(≥600 min/d and ≥3 valid days)
removed for bathing and sleeping;
non-wear time ≥20 min  with 0
counts, SB (h/day) deﬁned as <100
counts/minute
WC,  HDL, insulin,
HOMA-IR
5 of 6 Subsample in POS  table
Coefﬁcients of multivariate
linear regressions
Cooper et al.
(2014), UK
RP (type 2 diabetes),
ADDITION-Plus Study,
associations of SB and PA with
metabolic risk
394
m: 250
w:  144
63 60.3 (7.4)
m:  60.2 (7.4)
w: 60.5 (7.4)
Actiheart for 4 days; SB was
deﬁned as activity <1.5 MET
WC,  systolic BP,
HbA1c,
triglycerides, HDL
6 of 6 Coefﬁcients of multivariate
linear regression models, three
models with different level of
adjustment; adjusted to
possible confounders,
limitations mentioned;
difﬁcult to distinguish between
sitting and standing by using
Actiheart
Jakes et al. (2003),
UK
CD, European Prospective
Investigation into Cancer
(EPIC) study, association
between TV watching and
vigorous activity with obesity
and CVD risk proﬁle
14189 42 60.3 (45–74)
m:  61(9)
w: 59.9 (8.9)
Self-reported TV watching time
(four groups: hours/day), separated
for weekday and weekend day,
BMI, WC,  HC, WHR,
BF%, s/d BP, HbA1c,
triglycerides,
cholesterol, HDL,
LDL
4 of 6 Means adjusted for age and
multivariate adjusted; rational
for grouping of TV watching is
unclear, numbers per group are
not given
Gabriel et al.
(2012), USA
CD, Healthy Women Study
(HWS), association of PA with
coronary artery calciﬁcation
progression
148 0 73.2 (1.7) ActiGraph GT1M (uni-axial, waist)
for 7 days for 24 h (≥600 min/d and
≥4  days); non-wear time ≥ 60 min
with 0 counts; SB (min/day) was
deﬁned as <100 counts per minute
BMI, WC,  s/d BP,
cholesterol, LDL,
HDL, triglycerides,
glucose, insulin
5 of 6 Correlation coefﬁcients
between SB and biomarkers;
different methods used during
different FU state
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Table 1b (Continued)
Author, year,
country
Setting, study, aim No. of
partici-
pants
Male
(%)
Age, mean
(±SD/range)
[years]
Sedentary behaviour (SB)
assessment (method: measure)
Analyzed
biomarkers
CASP
score
Remarks
Gao et al. (2007),
USA
CD, association of TV watching
time and prevalence of MES
455 40 68.8 (≥60) Self-reported TV watching time
(quartiles: hours/day)
BMI, dichotomized:
WC,  triglycerides,
HDL, BP, glucose,
cholesterol/HDL,
WHR
5 of 6 Means for BMI, proportions
and multivariate adjusted ORs
for all dichotomized variables;
only Hispanics with Puerto
Rican or Dominican origin;
Gardiner et al.
(2011), Australia
CD, Australian Diabetes,
Obesity and Lifestyle (AusDiab)
study, relation between TV
watching and sitting time with
MES
1958 46 69 (≥60)
m: 69.6
w: 69
Questionnaire about TV and sitting
time (quartiles: hours/day)
Dichotomized: WC,
triglycerides, HDL,
BP, glucose
4 of 6 OR from multivariate adjusted
models; TV time and sitting
time measured separately.
Discrepancy in numbers, given
in  the paper, detected:
Females: No MES  (n = 643) and
MES (n = 460) −> n = 1103 does
not match total number of
1062;
Gennuso et al.
(2013), USA
CD, National Examination
Survey (NHANES) subsample,
association between SB and
CMRF
1914 52 74.6 (6.5) (≥65) ActiGraph AM-7164 (uniaxial,
waist) for 7 days (≥600 min/day
and ≥1 valid day) removed for
bathing and sleeping; non-wear
time ≥60 min with 0 counts; SB
(quartiles: hours/day) deﬁned as
<100 counts/minute
BMI, WC,  s/d BP,
cholesterol, HDL,
triglycerides, LDL,
glucose, HbA1c,
CRP
5 of 6 Least square means
multivariate adjusted; 1 day
enough for getting included in
analysis; analysis of
triglycerides, LDL and glucose
only on subsample of 809
people − we already excluded
papers because of accel. only
1 day
Hamer et al.
(2013), UK
CD, English Longitudinal Study
of Ageing (ELSA), association
between TV watching time.
CRP and depressive symptoms
4964 45.1 64.5 (8.9) Questionnaire about TV watching
time on 5 weekdays and weekend
separately (4 groups: hours/day)
CRP 4 of 6 Mean change in relation to a
reference group, two models
with different level of
adjustment
Henson et al.
(2013), UK
CD, “Walking Away from Type
2  Diabetes study”, association
between SB and inﬂammation
and adiposity
558 65 63.6 (7.7) ActiGraph GT3X (tri axial) for
7  days (≥600 min/d and ≥4 valid
days); non-wear time ≥60 min
with 0 counts; SB
(hours/day)deﬁned as <25
counts/15 sec s;
CRP, leptin, IL-6,
adiponectin,
leptin/adiponectin
5 of 6 Coefﬁcients of multivariate
linear regression models, three
models with different level of
adjustment; not mentioned
where accelerometer got
attached to;
Larsen et al.
(2014a), USA
CD, Rancho Bernardo Study
(RBS); associations of sitting
time with regional fat and
abdominal muscle
539
m:  135
w:  404
25 64.6 (7.4) (≥55) Single item about time spent in
leisure time sitting activities on a
typical weekday (tertiles:
hours/day)
BMI, TNF-a,
adiponectin, leptin,
IL-6, HDL, LDL,
triglycerides;
pericardial-, intra-
thoracic-,visceral-,
intermuscular- and
subcutaneous fat,
abdominal and
psoas muscle
4 of 6 Unadjusted means; low
sensitivity with measuring SB
by a single self-report item for
1  day
Lee et al. (2015),
USA
RP (adults with or at high risk
for knee osteoarthritis),
osteoarthritis initiative (OAI),
association between SB and
physical function
1168 45 66 (45–79) ActiGraph GT1M (uniaxial, waist)
for  7 days (≥600 min/d and
≥4 days) removed for bathing and
sleeping; non-wear time by
≥90 min  with 0 counts; SB
(quartiles: % of day) was deﬁned as
<100 counts per min
BMI  (3 categories),
gait speed, chair
stand rate
5 of 6 Unadjusted means for BMI  and
multivariate adjusted mean
differences between categories
of SB; adjusted to confounders
but only arthritis patients
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Lynch et al. (2010),
USA
RP (breast cancer survivors),
National Examination Survey
(NHANES), association of PA
and SB with adiposity
111 0 69.2 (13) ActiGraph 7164 (uniaxial, waist)
for 7 days (≥600 min/d) removed
for bathing and sleeping; non-wear
time ≥60 min with 0 counts; SB
(hours/day) was deﬁned as <100
counts/min;
BMI, WC,  insulin 5 of 6 Coefﬁcients of multivariate
linear regression models, three
models with different level of
adjustment; due to missing
values the number of subjects
varied (BMI: 106, WC:  100,
insulin: 35); not mentioned
how many days of
accelerometer were necessary
to get included in study
Lynch et al. (2011),
USA
CD, postmenopausal women of
National Examination Survey
(NHANES),
1024 0 63.0 (9.4) ActiGraph 7164 (uniaxial, waist)
for 7 days (≥600 min/d) removed
for bathing and sleeping; non-wear
time ≥60 min with 0 counts; SB
(hours/day) was deﬁned as <100
counts/min;
BMI, WC,  CRP,
fasting glucose,
insulin, HOMA-IR
5 of 6 Coefﬁcients of multivariate
linear regression models, three
models with different level of
adjustment; data not following
normal distribution were
transformed by natural
logarithm
Reaven et al.
(1991), USA
CD, relation between leisure
time PA and BP
641 0 66.5 (50–89) Questionnaire adapted from Health
Interview Survey with 17 leisure
time activities, (2 weeks)
HR, BMI, s/d BP,
fasting insulin, 2 h
insulin
3  of 6 Means adjusted for age (all),
means multivariate adjusted
(s/d BP)
Santos et al. (2012),
Portugal
CD, association of PA and SB
with functional ﬁtness
312
m: 117
w:  195
37.5 74.3(6.6) (≥65)
m: 74.2 (6.2)
w: 74.3(6.9)
ActiGraph, GT1M (waist) for 4 days
(2 weekdays and 2 weekend days)
(≥10 h/d and ≥3 days with ≥ 1
weekend day); non-wear time
≥60 min  0 counts; SB (min/day)
was  deﬁned as <100 counts per
minute
Chair stand
repetitions, arm
curl, 6MWT,  8 foot
up and go, chair sit
and reach, back
scratch
4 of 6 Coefﬁcients of multivariate
linear regression models, four
models with different level of
adjustment; nothing said about
exclusion criteria, not
mentioned if it was performed
in the same centre of same
examiners, not medication or
comorbidities got evaluated
Sardinha et al.
(2015), Portugal
CD, association of SB with
physical function
215
m: 87
w:  128
40 73.3 (5.9) (65–94)
m: 73.7 (6.2)
w: 73.0 (5.7)
ActiGraph, GT1M (waist) for 4 days
(2 weekdays and 2 weekend days)
(≥ 10 h/d and≥3 days with ≥1
weekend day); non-wear time
≥60 min  0 counts; SB (min/day)
was  deﬁned as <100 counts per
minute
6MWT,  8 foot up
and go, arm curl,
chair stand, chair
sit and reach, back
scratch
6 of 6 Good adjustment for possible
confounders
Stamatakis et al.
(2012), UK
CD, Health Survey for England
(HSE), association between SB
and CMRF
2765
with
self-
report;
649
with
accelerom-
eter
45 70 (≥60) ActiGraph GT1 M for 7 days
(≥600 min/d and ≥1 valid day),
non-wear time ≥60 min  with 0
count, SB (tertiles: min/day)
deﬁned as <100 counts/minute;
self-reported leisure-time SB
(tertiles: min/day)
BMI, WC,
cholesterol, HDL,
HbA1c,
cholesterol/HDL
ratio
5 of 6 Unadjusted means; 1 valid day
included in analysis, but 91%
had >5 days; different sample
sizes of accelerometer
measured and self-report
sample (sensitivity analysis
showed that this difference
might contribute to differential
associations; sample for blood
biomarker was considerably
smaller (1354/333)
6MWT  = 6 m walk test; ABI = ankle brachial index; AD = abdominal diameter; Apo = Apo lipoprotein; BP = blood pressure; BF% = percent of body fat; BFMI = body fat mass index (kg/m2); BMD  = bone mineral density; BMI  = body
mass  index; CCS = cross-sectional study; CD = community-dwelling; CG = control group; CMRF = cardio-metabolic risk factors; CRP = C-reactive protein; CV = cardiovascular; CVBM = cardiovascular biomarker; CVD = cardiovascular
disease;  DM-II = diabetes mellitus type 2; FEV1 = forced expiratory volume within 1 s; FFMI = fat free mass index (kg/m2); FVC = forced vital capacity; HC = hip circumference;HDL = high density lipoprotein; HOMA-IR = homeostatic
model  assessment of insulin resistance; HOMA% B = homeostatic model assessment of B-cell function; HR = heart rate; IG = intervention group; IL–6 = interleukin 6; LDL = low density lipoprotein; MES  = metabolic syndrome;
MET  = metabolic equivalent; NC = neck circumference; NHANES = National Health and Nutrition Examination Survey; NR = not reported; OR = odds ratio; PA = physical activity; PAD = peripheral artery disease; PAI = plasminogen
activator  inhibitor 1; PAL = physical activity level; PAS = physical activity scale; PASE = physical activity scale for the elderly; RCT = randomized controlled trials; RP = “risk population” deﬁned as population with speciﬁc illness
such  as diabetes or peripheral artery disease; s/d = systolic/diastolic; SB = sedentary behaviour; t-PA = tissue plasminogen activator; TNF-a = tumor necrosis factor a; WC = waist circumference; WHR  = waist to hip ratio.
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Table 2
Overview of biomarkers evaluated in the systematic review articles.
Study results Interpretation of the statistical signiﬁcance level in high
quality papers, adapted from CADTH (CADTH, 2016)
Category of
biomarker
Biomarker type Number of studies
by study type
(RCT/POS/CSS)
Statistically not
signiﬁcant studies
(n)
p < 0.05 in
un-adjusted results
(n)
p < 0.05 fully
adjusted (n, study
type, direction of
association +/−)
High quality
studies (n);
participants (n)
Results (%) Interpretation
Anthropo-metric
parameters
BMI  3/1/11 5 (2 RCT (Kirk et al.,
2009; Suboc et al.,
2014), 3 CSS
(Larsen et al.,
2014a; Lee et al.,
2015; Gao et al.,
2007))
10 9 (1 RCT+ (Kallings
et al., 2009), 1 POS+
(Fung, 2000), 7
CSS+ (Gennuso
et al., 2013; Jakes
et al., 2003; Reaven
et al., 1991; Bann
et al., 2015; Gabriel
et al., 2012;
Stamatakis et al.,
2012; Lynch et al.,
2011))
4 studies; 797
participants
50% signiﬁcant Mixed evidence for
association
WC  4/1/10 5 (4 RCT (Kirk et al.,
2009; Suboc et al.,
2014; Aadahl et al.,
2014; Kallings
et al., 2009), 1 CSS
(Gao et al., 2007))
10 8 (1 POS+ (Cooper
et  al., 2012), 7 CSS+
(Gabriel et al.,
2012; Gennuso
et  al., 2013; Jakes
et al., 2003; Lynch
et al., 2011;
Bankoski et al.,
2011; Cooper et al.,
2014; Stamatakis
et  al., 2012))
5 studies; 777
participants
20% signiﬁcant Generally no
evidence for
association
HC  0/0/1 0 1 1 CSS+ (Jakes et al.,
2003)
Not applicable
WHR  0/0/2 0 2 2 CSS+ (Gao et al.,
2007; Jakes et al.,
2003)
Not applicable
neck  circumference 1/0/0 0 1 1 RCT+ (Kallings
et al., 2009)
Not applicable
abdominal
diameter
1/0/0 1 RCT (Kallings
et al., 2009)
0 0 Not applicable
BF%  2/0/1 2 RCT (Aadahl et al.,
2014; Kallings
et al., 2009)
1 1 CSS+ (Jakes et al.,
2003)
Not applicable
fat  mass 1/0/0 0 1 1 RCT+ (Kallings
et al., 2009)
Not applicable
BF  in trunk 1/0/0 1 RCT (Kallings
et al., 2009)
0 0 Not applicable
fat  mass in trunk 1/0/0 1 RCT (Kallings
et al., 2009)
0 0 Not applicable
pericardial fat 0/0/1 0 1 1 CSS+ (Larsen
et al., 2014a)
Not applicable
intra-thoracic fat 0/0/1 0 1 0 Not applicable
visceral fat 0/0/1 0 1 0 Not applicable
intermuscular fat 0/0/1 0 1 0 Not applicable
subcutaneous fat 0/0/1 0 1 0 Not applicable
abdominal muscle 0/0/1 1 CSS (Larsen et al.,
2014a)
0 0 Not applicable
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psoas muscle 0/0/1 1 CSS (Larsen et al.,
2014a)
0 0 Not applicable
Systemic
parameters
systolic BP 3/0/8 7 (3 RCT (Kallings
et al., 2009; Kirk
et al., 2009; Suboc
et al., 2014), 4 CSS
(Gennuso et al.,
2013; Cooper et al.,
2014; Bankoski
et al., 2011;
Gardiner et al.,
2011))
4 3 CSS+ (Jakes et al.,
2003; Reaven et al.,
1991; Gabriel et al.,
2012)
3 studies; 331
participants
0% signiﬁcant No evidence for
association
diastolic BP 3/0/7 7 (3 RCT (Kallings
et al., 2009; Kirk
et al., 2009; Suboc
et al., 2014), 4 CSS
(Gennuso et al.,
2013; Gabriel et al.,
2012; Bankoski
et al., 2011;
Gardiner et al.,
2011))
3 1 CSS+ (Jakes et al.,
2003)
3 studies; 331
participants
0% signiﬁcant No evidence for
association
HR  1/0/1 1 RCT (Suboc et al.,
2014)
1 1 CSS+ (Reaven
et al., 1991)
Not applicable
brachial artery
diameter
1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
peak shear 1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
hyperemic peak
shear
1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
nitroglycerin
mediated dilation
1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
carotid-femoral
pulse wave velocity
1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
augmentation
index
1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
aortic s/d BP 1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
central retinal
artery equivalent
0/0/1 1 CSS (Anuradha
et al., 2011)
0 0 Not applicable
central retinal vein
equivalent
0/0/1 0 1 1 CSS+ (Anuradha
et al., 2011)
Not applicable
Blood lipids total cholesterol 4/1/4 7 (3 RCT (Aadahl
et al., 2014; Kirk
et al., 2009; Suboc
et al., 2014), 1 POS
(Fung, 2000), 3 CSS
(Gennuso et al.,
2013; Stamatakis
et al., 2012; Gabriel
et al., 2012))
2 2 (1 RCT+ (Kallings
et al., 2009), 1 CSS+
(Jakes et al., 2003))
Not applicable
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Table 2 (Continued)
Study results Interpretation of the statistical signiﬁcance level in high
quality papers, adapted from CADTH (CADTH, 2016)
Category of
biomarker
Biomarker type Number of studies
by study type
(RCT/POS/CSS)
Statistically not
signiﬁcant studies
(n)
p < 0.05 in
un-adjusted results
(n)
p < 0.05 fully
adjusted (n, study
type, direction of
association +/−)
High quality
studies (n);
participants (n)
Results (%) Interpretation
HDL 4/2/9 7 (4 RCT (Aadahl
et al., 2014; Kirk
et al., 2009; Suboc
et al., 2014;
Kallings et al.,
2009), 3 CSS
(Gennuso et al.,
2013; Larsen et al.,
2014a; Gabriel
et al., 2012))
8 6 (2 POS- (Cooper
et al., 2012; Fung,
2000), 4 CSS- (Jakes
et al., 2003;
Stamatakis et al.,
2012; Bankoski
et  al., 2011; Gao
et al., 2007))
6 studies; 1243
participants
33% signiﬁcant Generally no
evidence for
association
LDL  3/1/4 6 (3 RCT (Aadahl
et al., 2014; Suboc
et al., 2014;
Kallings et al.,
2009), 3 CSS
(Gennuso et al.,
2013; Larsen et al.,
2014a; Gabriel
et al., 2012))
2 2 (1 POS+ (Fung,
2000), 1 CSS+ (Jakes
et al., 2003))
4 studies; 729
participants
25% signiﬁcant Generally no
evidence for
association
LDL/HDL 1/0/0 1 RCT (Kallings
et al., 2009)
0 0 Not applicable
cholesterol/HDL 0/0/2 0 2 2 CSS+ (Gao et al.,
2007; Stamatakis
et  al., 2012)
Not applicable
triglycerides 3/1/8 8 (3 RCT (Aadahl
et al., 2014; Suboc
et al., 2014;
Kallings et al.,
2009), 1 POS (Fung,
2000), 4 CSS
(Gennuso et al.,
2013; Larsen et al.,
2014a; Gabriel
et al., 2012; Gao
et al., 2007))
4 2 CSS+ (Bankoski
et al., 2011; Jakes
et al., 2003)
4 studies; 729
participants
0% signiﬁcant No evidence for
association
ApoA1  1/1/0 1 RCT (Kallings
et al., 2009)
1 1 POS- (Fung, 2000) Not applicable
ApoB 1/0/0 1 RCT (Kallings
et al., 2009)
0 0 Not applicable
ApoB/ApoA1 1/0/0 1 RCT (Kallings
et al., 2009)
0 0 Not applicable
Lp(a) 0/1/0 1 POS (Fung, 2000) 0 0 Not applicable
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)
Glycemic
parameters
HbA1c 3/1/4 5 (2 RCT (Aadahl
et al., 2014; Kirk
et al., 2009), 1 POS
(Fung, 2000), 2 CSS
(Gennuso et al.,
2013; Cooper et al.,
2014))
3 2 (1 RCT+ (Kallings
et al., 2009), 1 CSS+
(Stamatakis et al.,
2012))
4 studies; 767
participants
25% signiﬁcant Generally no
evidence for
association
glucose  3/0/6 6 (3 RCT (Aadahl
et al., 2014; Suboc
et al., 2014;
Kallings et al.,
2009), 3 CSS (Lynch
et al., 2011; Gabriel
et al., 2012; Gao
et al., 2007))
3 2 CSS+ (Gennuso
et al., 2013;
Bankoski et al.,
2011)
3 studies; 263
participants
0% signiﬁcant No evidence for
signiﬁcant
association
insulin  (fasting) 2/2/4 2 (1 RCT (Suboc
et al., 2014), 1 POS
(Fung, 2000))
6 4 (1 RCT+ (Aadahl
et al., 2014), 1 POS+
(Cooper et al.,
2012), 2 CSS +
(Gabriel et al.,
2012; Reaven et al.,
1991))
4 studies; 1008
participants
50% Mixed evidence for
association
insulin  (after 2 h) 0/0/1 0 1 1 CSS- (Reaven
et al., 1991)
Not applicable
HOMA-IR 1/1/1 1 RCT (Suboc et al.,
2014)
2 1 POS+ (Cooper
et al., 2012)
Not applicable
QUICKI 1/0/0 1 RCT (Suboc et al.,
2014)
0 0 Not applicable
C-peptide 0/1/0 0 1 1 POS+ (Fung,
2000)
Not applicable
Performance
biomarkers
6MWT  0/0/2 2 (1 CSS (Sardinha
et al., 2015), NR*
(Santos et al.,
2012))
0 0 Not applicable
8  foot up and go 0/0/2 2 (1 CSS (Sardinha
et al., 2015), NR*
(Santos et al.,
2012))
0 0 Not applicable
grip  strength 0/0/1 1 CSS (Bann et al.,
2015)
0 0 Not applicable
gait  speed 0/0/1 0 1 1 CSS- (Lee et al.,
2015)
Not applicable
arm  curl 0/0/2 NR* (Santos et al.,
2012)
1 0 Not applicable
Chair stand rate 0/0/3 NR* (Santos et al.,
2012)
2 1 CSS- (Lee et al.,
2015)
Not applicable
Chair sit and reach 0/0/2 NR* (Santos et al.,
2012)
1 0 Not applicable
Back scratch 0/0/2 1 (CSS (Sardinha
et al., 2015), NR*
(Santos et al.,
2012))
0 0 Not applicable
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Table 2 (Continued)
Study results Interpretation of the statistical signiﬁcance level in high
quality papers, adapted from CADTH (CADTH, 2016)
Category of
biomarker
Biomarker type Number of studies
by study type
(RCT/POS/CSS)
Statistically not
signiﬁcant studies
(n)
p < 0.05 in
un-adjusted results
(n)
p < 0.05 fully
adjusted (n, study
type, direction of
association +/−)
High quality
studies (n);
participants (n)
Results (%) Interpretation
Inﬂammatory
biomarkers
CRP 1/0/4 1 RCT (Suboc et al.,
2014)
4 2 CSS+ (Gennuso
et al., 2013; Hamer
et al., 2013)
Not applicable
Fibrinogen 0/1/0 1 POS (Fung, 2000) 0 0 Not applicable
IL-6  0/0/2 1 CSS (Larsen et al.,
2014a)
1 1 CSS+ (Henson
et al., 2013)
Not applicable
Others Leptin 0/1/3 1 CSS (Larsen et al.,
2014a)
3 2 (1 POS+ (Fung,
2000), 1 CSS+
(Allison et al.,
2012))
Not applicable
Adiponectin 0/0/3 2 CSS (Allison et al.,
2012; Henson
et al., 2013)
1 1 CSS+ (Larsen
et al., 2014a)
Not applicable
leptin/adiponectin
ratio
0/0/1 0 1 0 Not applicable
adiponectin/leptin
ratio
0/0/1 0 1 1 CSS− (Allison
et al., 2012)
Not applicable
TNF-a 0/0/2 1 CSS (Larsen et al.,
2014a)
1 1 CSS+ (Allison
et al., 2012)
Not applicable
Resistin 0/0/1 1 CSS (Allison et al.,
2012)
0 0 Not applicable
Remark: Results from Cooper et al. (2012) are only listed in POS results, not additionally in CSS column; *Santos et al. (Santos et al., 2012) calculated a composite Z-score, but didn’t report separate associations for each biomarker
with  SB.
6MWT  = 6 m walk test; adj. = adjusted; Apo = Apo lipoprotein; BF% = percent of body fat; BMI  = body mass index (kg/m2); BP = blood pressure; CSS = cross-sectional study; CRP = C-reactive protein; FFMI = fat free mass index (kg/m2);
HbA1c = speciﬁc glycated hemoglobin; HC = hip circumference; HDL = high density lipoprotein; HOMA-IR = homeostatic model assessment of insulin resistance; HR = heart rate; IL = interleukin; LDL = low density lipoprotein;
Lp(a)  = lipoprotein a; NR = not reported; PA = physical activity; POS = prospective observational studies; QUICKI = quantitative insulin sensitivity check test; RCT = randomized controlled trials; reg. coeff. = regression coefﬁcient;
s/d  = systolic/diastolic; sig. = signiﬁcant; SB = sedentary behaviour; ST = sedentary time; TNF-a = tumor necrosis factor a; unadj. = unadjusted; WC  = waist circumference; WHR  = waist to hip ratio.
K
.
 W
irth
 et
 al.
 /
 A
geing
 R
esearch
 R
eview
s
 35
 (2017)
 87–111
 
101
Table 3
Details of randomized controlled trials (RCTs), prospective observational studies (POS) and cross-sectional studies (CSS) including signiﬁcant associations of biomarkers with Sedentary Behaviour.
Author, Year No. of
participants
What was analysed?
What was measured?
Measured
biomarkers
Main results (95%CI) or [SD] or {SE} P-value CASP score Remarks
RCTs
Kallings
et al. (2009)
CG: 54
IG: 47
Signiﬁcant differences
between IG and CG in mean
change (MC) of biomarker
from baseline (B) to follow
up (FU); reducing SB was
measured, thus changes are
negative
BMI  (kg/m2) MC IG: −0.6 (−0.9 to −0.3) vs. MC CG: −0.2
(−0.4 to 0.0)
0.02
5/6
MC from B to FU in sitting
time (hours/day) in CG with
−1 h/d (p < 0.001) and IG
with −2 h/d (p < 0.0.01)
NC  (cm) MC IG: −1.2 (−1.6 to −0.8) vs. MC CG: −0.6
(−1.0 to −0.2)
0.01
Fat mass (kg) MC IG: −1.7 (−2.5 to −0.9) vs. MC CG: −0.6
(−1.2 to −0.1)
0.03
HbA1c (%) MC IG: −0.1 (−0.2 to 0.0) vs. MC CG: 0.2
(0.1 to 0.3)
0.001
Cholesterol
(mmol/l)
MC IG: −0.3 (−0.6 to 0.0) vs. MC CG: 0.1
(−0.1 to 0.1)
0.04
Aadahl et al.
(2014)
Total: 66
IG: 38
CG: 28
Mean difference (MD) in
change of fasting serum
insulin from baseline (B) to
follow up (FU) between IG
and CG for reducing SB
Fasting insulin
(pmol/l)
−0.51 (−0.01 to −1.00) 0.04 5/6 CG means [SD] of sitting time
in  B = 9.8 [2.0] and FU = 10.2
[1.9]; IG means [SD] of sitting
time in B = 9.27 [1.9] and
FU = 8.7 [1.5]
POS
Fung
(2000) 466
Pearson correlation
coefﬁcient (PCC) of television
hours and biomarker; linear
regression coefﬁcient (lrc) for
1994 TV hours[1] or average
TV hours in 1988–1994[2]
BMI  (kg/m2) PCC: 0.13 <0.01
5 of 8
Lrc calculated for increment
of  14 h television watching
per week
Leptin (ng/ml) PCC: 0.15 lrc: 1.3 {0.5}[2], adj. to BMI 0.8
{0.4}[2]
<0.01;
<0.01,
<0.05
C-peptide
(ng/dl)
PCC: 0.12 <0.05
ApoA1 (mg/dl) lrc: −5.3 {2.0}[1]
adj. to BMI  −4.9 {2.0}[1]
<0.05
<0.05
HDL (mg/dl) lrc: −3.9 {1.2}[1]
adj. to BMI  −3.4 {1.2}[1]
<0.01
<0.01
LDL  (mg/dl) lrc: 6.1 {2.9}[1]
adj. to BMI  6.1 {2.9}[1]
<0.05
<0.05
Cooper
et al. (2012)
528/380
Mean change (MC) in
biomarker from baseline (B)
to  follow-up; cross-sectional
regression coefﬁcient (csrc)
for baseline sample (bs) and
longitudinal sample (ls) or
longitudinal linear regression
coefﬁcient (llrc); additionally
adj. to WC[3]
WC (cm) MC: −1.9 (−2.3 to −1.4)
B csrc: 1.8 (0.9–2.8)
ls csrc: 1.8 (0.6–2.9)
<0.001
<0.001
0.002 5 of 8
Csrc and llrc calculated for ST
in hours/day
HDL  (mmol/l) bs B csrc: −0.03 (-0.06 to −0.01)
bs B csrc[3]: −0.03, (−0.05 to −0.004)
ls B csrc: −0.04 (−0.076 to −0.01)
ls B csrc[3]: −0.05 (−0.07 to −0.00)
ls FU csrc: −0.05 (−0.088 to −0.020)
ls FU csrc[3]: −0.05 (−0.08 to −0.01)
llrc: −0.04 (−0.08 to −0.01)
0.005
0.02
0.006
0.01
0.002
0.003
0.007
Insulin (pmol/l) MC: −9.4 (−14.4 to −4.4)
bs b csrc: 8.2 (2.8 to 13.6)
ls B csrc: 12.0 (5.0 to 19.1)
ls B csrc[3]: 8.5 (1.8 to 15.2)
llrc: 8.1 (1.5 to 14.7)
<0.001
0.003
0.001
0.01
0.01
HOMA-IR MC: −0.36 (−0.6 to −0.0)
bs B csrc: 0.4 (0.1 to 0.7)
ls B csrc: 0.6 (0.2 to 0.9)
ls B csrc[3]: 0.4 (0.1 to 0.8)
ls llrc: 0.4 (0.0 to 0.9)
0.03
0.004
0.001
0.009
0.02
CSS
Allison
et al. (2012) 1543
Linear regression coefﬁcient
(lrg) calculated for natural
logarithm of biomarker and
increment of SB (790
MET-minutes/week) adj. for
confounders or additionally
to BMI and more conf.[4], or
add. to WC[5]
Leptin (ng/ml) 0.15 (0.10 to 0.20)
0.07 (0.04 to 0.11)[4]
0.07 (0.03 to 0.10)[5]
<0.05
<0.05
<0.05
4 of 6
TNF-a (pg/ml) 0.04 (0.01 to 0.06)
0.03 (0.01 to 0.06)[4]
0.03 (0.00 to 0.06)[5]
<0.05
<0.05
<0.05
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Table 3 (Continued)
Author, Year No. of
participants
What was analysed?
What was measured?
Measured
biomarkers
Main results (95%CI) or [SD] or {SE} P-value CASP score Remarks
Adiponectin/
Leptin ratio
−0.17 (−0.23 to −0.11)
−0.08 (−0.12 to −0.03)[4]
0.07 (−0.11 to −0.02)[5]
<0.05
<0.05
<0.05
Anuradha et al.
(2011)
5893 Multivariate-adjusted mean
difference for highest
compared to lowest quartile
of TV viewing time (>3 h/d
to <1 h/d)
Central retinal
vein equivalent
(m)
1.8 (0.4 to 3.2) <0.05 4 of 6
Bankoski
et al. (2011) 1367
Age and sex adjusted means
of biomarker and MES risk
proﬁle (according to the ATP
III guidelines) for duration of
ST[6] (in hours/day) and % of
ST  of total wear time[7]
Large WC* no risk 9.2 {0.1}[6] to risk 9.6 {0.1}[6]
no risk 62.6 {0.4}[7] to risk 66.6 {0.6}[7]
0.04
<0.01
5 of 6Low  HDL* no risk 64.2 {0.5}[7] to risk 67.7 {0.6}[7] <0.01
High
Triglycerides*
no risk 9.2 {0.1}[6] to risk 9.6 {0.1}[6]
no risk 63.8 {0.5}[7] to risk 67.0 {0.6}[7]
0.05
<0.01
High glucose no risk 63.6 {0.5}[7] to risk 66.0 {0.6}[7] <0.01
Bann et al.
(2015)
1130 Mean differences in BMI  per
hour/day increase in ST
measured by accelerometer
(ACC)[8] and self-report
(SR)[9]
BMI  (kg/m2) ACC minimally adj.: 0.42 (0.13 to 0.71)
ACC fully adj.: 0.44 (0.14 to 0.74)
SR  minimally adj.: 0.37 (0.06 to 0.67)
SR  fully adj.: 0.51 (0.19 to 0.82)
0.005
0.004
0.01
0.002
4  of 6
Cooper et al.
(2014)
394
m:  250
w:  144
Linear reg. coeff. for ST and
WC,  crude, adj. to
confounders and add. adj. to
PA
WC  (cm) crude: 0.80 (0.31 to 1.29)
adj.: 0.97 (0.46 to 1.48)
adj. + PA: 0.68 (0.01 to 1.35)
<0.05
<0.05
<0.05
6 of 6 Linear regression analyses
performed for ST in
hours/day
Jakes et al.
(2003) 14189
Age adjusted mean value of
biomarker in relation to
television viewing h/d (<2 h,
2-2.9, 3-3.9, >4) in men  and
women, add. adj. to
confounders[10]
BMI  (kg/m2) m:  26.1 [3.1], 26.4 [3.0], 26.7 [3.2], 27.1
[3.2]
w:  25.3 [3.9], 26.0 [4.1], 26.2 [4.0], 26.9
[4.4]
<0.001
<0.001
4 of 6
WC  (cm) m:  94.0 [9.1], 94.9 [8.8], 95.7 [9.2], 97.0
[9.3]
w:  79.6 [9.5], 80.7 [10.0], 81.5 [9.9], 82.9
[10.4]
<0.001
<0.001
HC (cm) m:  102.3 [5.7], 102.8 [5.7], 103.0 [6.2],
103.7 [6.6]
w: 102.0 [8.1] 103.2 [8.9], 103.5 [8.4], 104.7
[9.3]
<0.001
<0.001
WHR  m:  0.92 [0.06], 0.92 [0.05], 0.93 [0.05], 0.93
[0.05]
w:  0.78 [0.05], 0.78 [0.06], 0.79 [0.06], 0.79
[0.06]
<0.001
<0.001
BF (%) m:  22.5 [6.6], 23.4 [6.2], 24.3 [7.5], 25.3
[7.0]
w:  37.1 [8.6], 38.9 [8.8], 40.0 [8.6], 41.6
[9.3]
<0.001
<0.001
s BP (mmHg) m:  135.0 [16.8], 136.4 [17.7], 138.1 [17.7],
138.4 [19.0]
m[10]: 135.6 [15.1], 136.7 [15.4], 137.7
[14.9], 137.8 [15.6]
w:  130.9 [15.1], 132.3 [11.6], 133.4 [11.2],
134.0 [11.7]
w[10]: 131.6 [16.8], 132.6 [13.3], 133.3
[13.3], 133.1 [14.3]
<0.001
<0.001
<0.001
<0.01
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d BP (mmHg) m:  83.2 [12.6], 83.7 [13.3], 84.9 [13.3], 85.6
[14.3]
m[10]: 83.6 [11.3], 83.9 [11.6], 84.6 [11.2],
85.1 [11.7]
w:  79.2 [7.5], 80.1 [7.7], 80.7 [7.5], 81.1
[7.8]
w[10]: 79.7 [8.4], 80.3 [8.9], 80.7 [8.9], 80.5
[9.5]
<0.001
<0.001
<0.001
<0.01
Triglycerides
(mmol/l)
m:  1.70 (0.8–3.6), 1.80 (0.8–3.8), 1.82
(0.9–3.8), 1.92 (0.9–4.1)
m[10]: 1.73 (0.8–3.6), 1.82 (0.9–3.9), 1.80
(0.9–3.7), 1.88 (0.9–4.0)
w:  1.38 (0.6–3.1), 1.40 (0.6–3.3), 1.49
(0.6–3.6), 1.54 (0.6–3.9)
w[10]: 1.42 (0.6–3.2), 1.42 (0.6–3.4), 1.48
(0.6–3.5), 1.49 (0.6–3.8)
<0.001
<0.01
<0.001
<0.001
Cholesterol
(mmol/l)
m:  5.91 [1.26], 5.93 [1.33], 5.96 [1.33], 6.05
[1.43]
m[10]: 5.92 [1.13], 5.93 [1.16], 5.96 [1.12],
6.04 [1.17]
w:  6.17 [1.13], 6.22 [0.77], 6.27 [0.75], 6.28
[0.78]
w[10]: 6.19 [1.26], 6.23 [0.89], 6.27 [0.89],
6.26 [0.95]
<0.001
<0.01
0.001
<0.01
HDL (mmol/l) m:  1.28 (0.6–2.7), 1.23 (0.6–2.6), 1.22
(0.6–2.5), 1.20 (0.6–2.6)
m[10]: 1.27 (0.6–2.7), 1.22 (0.6–2.6), 1.22
(0.6–2.5), 1.21 (0.6–2.6)
w:  1.63 (0.7–3.7), 1.58 (0.7–3.8), 1.57
(0.7–3.7), 1.51 (0.6–3.8)
w[10]: 1.60 (0.7–3.6), 1.57 (0.7–3.7), 1.57
(0.7–3.7), 1.54 (0.6–3.9)
<0.001
<0.01
<0.001
<0.001
LDL (mmol/l) m:  3.75 [0.84], 3.77 [0.89], 3.82 [0.89], 3.87
[0.95]
m[10]: 3.75 [0.75], 3.77 [0.77], 3.82 [0.75],
3.87 [0.78]
w:  3.82 [0.75], 3.90 [0.77], 3.93 [0.75], 3.97
[0.78]
w[10]: 3.85 [0.84], 3.91 [0.89], 3.93 [0.89],
3.95 [0.95]
<0.001
<0.01
<0.001
<0.01
Gabriel
et al. (2012) 148
Pearson cc between
biomarker and accelerometer
measured ST (in min/d)
BMI  (kg/m2) PCC: 0.18 <0.05
5 of 6
WC  (cm) PCC: 0.21 <0.01
S  BP (mmHg) PCC: 0.17 <0.05
Insulin (mU/dl) PCC: 0.24 <0.01
Gao et al.
(2007) 455
OR of unfavourable
biomarker proﬁle by
quartiles of TV viewing time
(0–1.5 h = reference,
1.6-3.4 h, 3.5-5.5 h, 5.6–18 h),
adj. for confounders[11], add.
for dietary habits[12], add. for
ADL[13]
Low HDL* 1 (ref), 0.9 (0.4–2.0), 1.2 (0.5–2.7), 2.5
(1.0–5.9)
0.02[11],
0.02[12],
0.01[13]
5 of 6 P-values for linear trends
High  choles-
terol/HDL
ratio*
1 (ref), 1.2 (0.7–2.1), 1.3 (0.7–2.4), 2.0
(1.1–3.7)
0.01[11],
0.03[12],
0.04[13]
High WHR* 1 (ref), 1.6 (0.8–3.1), 2.3 (1.1–4.8), 3.9
(1.8–8.4)
0.0003[11],
0.0008[12],
0.0006[13]
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Table 3 (Continued)
Author, Year No. of
participants
What was analysed?
What was measured?
Measured
biomarkers
Main results (95%CI) or [SD] or {SE} P-value CASP score Remarks
Gennuso
et al. (2013) 1914
Association of least square
means of biomarkers with
quartiles of sedentary hours
(0–7.92, 7.93–8.17,
8.18-10.63, >10.64)
BMI  (kg/m2) 26.6 [0.6], 27.4 [0.5], 27.8 [0.5], 28.8 [0.4] 0.01
5 of 6
P-values
for linear
trends
WC  (cm) 98.2 [1.6], 100.2 [1.3], 101.9 [1.4], 104.4
[1.0]
<0.01
Glucose
(mg/dl)
115.0 [1.2], 114.8 [1.2], 119.2 [1.2], 119.8
[1.2]
0.04
CRP (mg/dl) 0.24 [1.15], 0.24 [1.12], 0.26 [1.12], 0.34
[1.14]
<0.01
Hamer et al.
(2013)
4964 Dose-response association
for TV viewing (<2 = Ref., 2–4,
4–6, >6 h/d) and log
transformed mean CRP
values, adj. for age, sex[14];
further adj. to PA, BMI[15]
CRP (log
transformed)
Ref., 0.11 (0.04 to 0.18), 0.27 (0.2 to 0.34),
0.29 (0.22 to 0.36)[14]
0.04 (−0.03 to 0.1), 0.12 (0.06 to 0.19), 0.11
(0.04 to 0.17)[15]
<0.001
<0.001
4 of 6
Henson et al.
(2013)
558 Regression coeff. for ST
(in h/day) with biomarker,
adj. to confounders, add. to
PA[16], add. adj. to BMI  and
HbA1c[17]
IL-6 (pg/ml) 0.242 {0.056}, 0.231 {0.073}[16], 0.212
{0.072}[17]
<0.001,
0.002[16],
0.003[17]
5 of 6
Larsen et al.
(2014a)
539
m:  135
w:  404
Variance (V) in mean values
of biomarker and ST tertiles
or cross-sectional regression
coefﬁcient (csrc) of
biomarker to ST tertiles
(<2.5, 2.5–4, >4 sitting
hours/day), unadj., adj. to
demographics[18], to CVD
RF[19], to BMI[20], to
inﬂammatory markers[21]
Adiponectin
(g/ml)
V: 10.4 [6.0], 9.4 [4.9], 10.8 [6.6], 10.8 [5.9] 0.032
4 of 6
Pos. assoc. for V of
intra-thoracic fat (p = 0.018),
intermuscular fat (p = 0.001)
and subcutaneous fat
(p = 0.034) but not sig. in csrc
Intra-thoracic
fat  (cm2)
V: 71.8 [64.1], 61.2 [50.5], 75.8 [70.9], 80.0
[66.1]
0.018
Intermuscular
fat (cm2)
V: 21.4 [11.0], 19.4 [8.8], 23.5 [12.1], 21.4
[11.3]
0.001
Subcutaneous
fat (cm2)
V: 253.8 [122.7], 243.4 [106.3], 273.2
[131.4], 246.6 [126.2]
0.034
Pericardial fat
(cm2)
csrc: 3.19 (0.45 to 5.92)
csrc[18]: 3.19 (0.45 to 5.92)
csrc[19]: 3.32 (0.84 to 5.81)
csrc[20]: 2.39 (0.07 to 4.72)
csrc[21]: 2.45 (0.12 to 4.77)
0.022
0.022[18]
0.009[19]
0.044[20]
0.039[21]
Lee et al.
(2015) 1168
Unadj.[22] as well as adj.[23]
average differences (AD) in
function (as biomarker)
between SB quartiles (Q2 vs.
Q1, Q3 vs. Q1 and Q4 vs. Q1)
Gait speed
(feet/s)
AD[22]: 0.35 [0.08], 0.44 [0.08], 0.44 [0.08]
AD[23]: 0.20 [0.07], 0.21 [0.08], 0.21 [0.08]
<0.001[22]
<0.001[23] 5 of 6
Chair stand
rate
(stands/min)
AD[22]: 3.00 [0.95], 3.28 [0.98], 5.30 [0.95]
AD[23]: 1.85 [0.90], 1.46 [0.96], 3.43 [0.98]
<0.001[22]
0.0016[23]
Lynch et al.
(2011) 1024
Association of SB quartiles
(  < 7.74, 7.74- < 8.8,
8.8- < 9.84, ≥9.84 h/d), adj. in
model 1[24] to age; model 2
for BMI: ethnicity, alcohol
intake, age at ﬁrst birth, age
at menarche; model 2[25] for
WC:  ethnicity, educational
attainment, marital status,
annual family income,
alcohol intake, age at ﬁrst
birth
BMI  model 1[24]: 26.7 (25.9 to 27.5), 27.6 (26.8
to  28.5), 27.6 (26.6 to 28.6), 29.9 (28.6 to
31.2)
model 2[25]: 27.2 (26.4 to 27.9), 27.7 (26.9
to  28.6), 27.5 (26.6 to 28.4), 29.3 (28.1 to
30.5)
<0.001[24]
0.02[25] 5 of 6
CRP, insulin, HOMA-IR
showed also sig. pos. trend
with SB quartiles, sig. after
multivariate adj., but ns after
adj. to WC;  all results as
marginal means for each
quartile, back-transformed
for all log-transformed
outcomes
WC  model 1[24]: 91.9 (89.7 to 94.2), 94.7 (92.9
to  96.5), 95.7 (93.3 to 98.1), 102.1 (99.4 to
104.8)
model 2[25]: 93.2 (90.8 to 95.7), 95.1 (93.1
to  97.1), 95.5 (93.2 to 97.9), 100.5 (97.9 to
103.1)
<0.001[24]
0.003[25]
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Reaven
et al.
(1991)
641
Mean values of age adj.
biomarker by exercise
category (none, light,
moderate, heavy); s BP
additionally adj. to age[26],
age + BMI[27],
age + BMI  + alcohol + estrogen[28],
age + BMI  + fasting insulin[29],
age + BMI  + 2 h insulin[30]
HR (beats/min) 66.5, 64.8, 63.9, 61.4 0.01
3 of 6
P-values for linear trends;
values for D BP were ns when
unadj. but linear trend adj. to
same confounders as S BP
were sig (p = 0.006[24],
p = 0.044[25], p = 0.049[26],
p  = 0.034[27], p = 0.025[28])
BMI  (kg/m2) 26.3, 24.1, 25.1, 23.4 0.05
S  BP (mmHg) 143.3, 136.8, 130.3, 122.6
142.1, 135.5, 133.0, 130.3[26]
140.8, 135.6, 132.5, 131.3[27]
140.7 135.6 132.5 131.4[28]
140.7 135.5 132.5 131.4[29]
140.9 134.9 131.0 131.3[30]
<0.001
0.003
0.012
0.013
0.014
0.010
Fasting Insulin
(U/ml)
16.9, 13.7, 12.4, 11.2 0.002
2  h Insulin
(U/ml)
15.0, 88.5, 79.2, 66.2 0.001
Stamatakis
et al. (2012)
2765 (SR)
649 (accel.)
Mean values of biomarker
and tertiles of self-reported
(SR; <291, 291–394, >
394 min/d) or accelerometer
measured (accel.; <507,
507–571, > 571 min/d) ST
BMI  (kg/m2) SR: 27.4 [4.5], 27.9 [4.6], 28.5 [5.1]
accel.: 27.1 [4.0], 28.6 [4.9], 28.5 [4.7]
<0.01
<0.01
5 of 6
P-value for one-way ANOVA
test; a sig. pos. multivariate
reg. coeff. was calculated for
SR SB with BMI  and HbA1c
and similar for accel.
measured SB with
cholesterol and HbA1c, which
was ns after further adj.
WC  (cm) SR: 94.8 [13.1], 96.0 [12.8], 98.3 [13.4]
accel.: 93.1 [12.7], 96.5 [13.7], 99.6 [12.8]
<0.01
<0.01
HDL (mmol/l) SR: 1.6 [0.4], 1.6 [0.4], 1.5 [0.4]
accel.: 1.7 [0.4], 1.6 [0.4], 1.5 [0.4]
<0.01
<0.01
HbA1c (%) SR: 5.8 [0.7], 5.8 [0.6], 6.0 [0.9]
accel.: 5.8 [0.6], 5.8 [0.6], 6.0 [0.8]
<0.01
0.01
Cholesterol/HDL
ratio
SR: 3.9 [1.0], 4.0 [1.0], 4.1 [1.2] 0.01
accel. = accelerometer; AD = average differences; adj. = adjusted; ADL = activities of daily living; B = baseline; BF% = percent of body fat; BMI  = body mass index; BP = blood pressure; bpm = beats per minute; cc = correlation coefﬁcient;
CI  = conﬁdence interval; coeff. = coefﬁcient; CG = control group; CMRF = cardio-metabolic risk factors; CRP = C-reactive protein; csrc = cross-sectional regression coefﬁcient; FU = follow up; HbA1c = glycated hemoglobin; HC = hip
circumference; HDL = high density lipoprotein; HOMA-IR = homeostatic model assessment of insulin resistance; HR = heart rate; IG = intervention group; IL = interleukin; LDL = low density lipoprotein; lrc = linear regression coef-
ﬁcient;  MC = mean change; MD = mean difference; MES = metabolic syndrome; NC = neck circumference; neg. = negative; NR = not reported; OR = odds ratio; PCC = Pearson correlation coefﬁcient; pos. = positive; POS = prospective
observational studies; RCT = randomized controlled trials; ref = reference; S/D = systolic/diastolic; SB = sedentary behaviour; SD = standard deviation; SE = standard error; sig. = signiﬁcant; SR = self report; ST = sedentary time;
TNF-a  = tumor necrosis factor alpha; unadj. = unadjusted; V = Variance; WC = waist circumference; WHR  = waist to hip ratio.
* According to the deﬁnitions of Adult Treatment Panel III (ATP-III); Cholesterol/HDL ratio > 4.5 was considered as high.
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3.5. Risk of bias (quality) appraisal
After revising the 40 articles by CASP criteria (CASP, 2016) and
general quality criteria (correctness of data illustration, selection
or reporting bias, misclassiﬁcation etc.) we excluded 13 CSS for the
following quality linked issues [CASP score] and 1 POS:
a SB was not sufﬁciently measured: Ewald et al. (2010) [3 of 6] and
Bianchi et al. (2008) [2 of 6] evaluated time spent being sedentary
with the Physical Activity Scale for the Elderly (PASE) and Kaino
et al. (2013) [2 of 6] used the Japan Arteriosclerosis Longitudinal
Study Physical Activity Questionnaire (JALSPAQ) which are good
instruments to measure PA but weak in calculating SB; Calderon-
Garcia et al. (2013) [4 of 6] calculated ST by asking “How much do
you exercise or strain yourself physically in your leisure time?”,
which had poor validity.
b Missing information about recruitment or cohort characterstics
(Azzabou et al., 2015);
c SB deﬁned as simply being the opposite of PA, as in Gába et al.
(2012) [3 of 6] or unclear deﬁnition of sedentariness (Elkan et al.,
2011) [1 of 6], Belza et al. (2001) [3 of 6]);
d Poor quality of exposure or outcome assessment; e.g. Inoue et al.
(2012) [3 of 6] calculated BMI  by self- reported weight and height,
among other issues;
e Missing evaluation or lack of adjustment for important confound-
ing factors (comorbidities, medication status etc.), e.g. Li et al.
(2009) [2 of 6], Babaroutsi et al. (2005) [3 of 6] and others (Azzabou
et al., 2015; Elkan et al., 2011; Belza et al., 2001; Inoue et al., 2012);
f Evidence of selection bias – like in Knight and Bermingham (1999)
[2 of 6] who compared a cohort from Day Care Centre to a cohort
from a bowling club;
g Implausible or irreproducible data – e.g. implausible data of sam-
ple size and sample origin (Azzabou et al., 2015) [3 of 6]);
h Biomarker calculated by self-report, like BMI  from self-reported
weight and height or SB and biomarkers weren’t measured at the
same point in time (Scott et al., 2015));
i We  excluded the POS from Wijndaele et al. (2009) [3 of 8] because
BMI  was calculated by self-report weight.
After the exclusion of these studies only 2 articles (Reaven et al.,
1991; Chase et al., 2014) with a low CASP-score ≤ 3 remained. The
mean CASP score of RCTs was 5 out of 6, for cohort studies 5 out of
8 and for CSS 4.5 out of 6.
3.6. Relation of SB and biomarkers
3.6.1. Sedentary behaviour and anthropometric and systemic
biomarkers
Of the 15 studies exploring this biomarker, 9 demonstrated a
positive association, including 1 RCT (Kallings et al., 2009) and 1
POS (Fung, 2000) study (Table 2 and 3), whereas 2 RCTs (Suboc et al.,
2014; Kirk et al., 2009) didn’t show statistically signiﬁcance, thus
there is mixed evidence for the association of SB to BMI. WC was
also positively associated with SB in 1 POS (Cooper et al., 2012) and
7 CSS, but were not statistically signiﬁcant in 4 RCTs. Relationships
between SB and both systolic BP (3 of 11 studies reporting this
biomarker found positive association) and diastolic BP (1 out of
10 studies found a positive associations) were found, whereas the
majority showed non-signiﬁcant results. Neck circumference and
fat mass were positively correlated to SB but were investigated in
only one RCT. There was only limited or no evidence for the other
anthropometric biomarkers (see Table 2 and 3).
3.6.2. Sedentary behaviour and blood lipids
Total cholesterol, HDL, low density lipoprotein (LDL) and triglyc-
erides were the main focus in the investigated studies. If statistically
signiﬁcant association was  prevalent, it was  in an unfavourable
direction. For total cholesterol positive association was found in
1 RCT (Kallings et al., 2009), whereas the 3 RCTs (Aadahl et al.,
2014; Suboc et al., 2014; Kirk et al., 2009) and 1 POS (Fung, 2000)
didn’t show any statistically signiﬁcant association. HDL was sta-
tistically signiﬁcant negatively associated with SB in 2 POS (Cooper
et al., 2012; Fung, 2000) but results in 4 RCTs (Aadahl et al., 2014;
Suboc et al., 2014; Kirk et al., 2009; Kallings et al., 2009) were sta-
tistically not signiﬁcant. Similar results were detected for the other
blood lipids (see Tables 2 and 3). Most RCTs didn’t show statistically
signiﬁcant results, hence there is generally no evidence for an asso-
ciation of SB and blood lipids. Results linking SB and blood lipids
mostly derived from CSS studies and thus should be interpreted
accordingly.
3.6.3. Sedentary behaviour and glycaemic biomarkers
There was some indication found of an unfavourable impact of
SB on fasting insulin levels, with statistically signiﬁcant associa-
tions in 1 RCT (Aadahl et al., 2014) and 1 POS (Cooper et al., 2012).
However 1 RCT (Suboc et al., 2014) and 1 POS (Fung, 2000) didn’t
show any association, which lead to mixed evidence for a possi-
ble impact of SB on insulin levels. For HbA1c, only 1 RCT (Kallings
et al., 2009) was statistically signiﬁcant. HOMAR-IR (Cooper et al.,
2012) and C-peptide (Fung, 2000) were positively correlated to SB
in 1 POS. Glucose levels did not appear to be related to SB in 3 RCTs
(Aadahl et al., 2014; Suboc et al., 2014; Kallings et al., 2009). Initially
equivocal results in 2 CSS, with 1 positive (Gennuso et al., 2013) and
1 negative association (Bankoski et al., 2011) were clariﬁed by con-
tacting the author. In both studies SB was  associated with higher
blood glucose levels. The impact of SB on glycaemic biomarkers was
limited and largely restricted to CSS (Tables 2 and 3), precluding
deﬁnitive conclusion.
3.6.4. SB and muscle or physical performance biomarkers
Muscle tissue, performance, strength or other performance
components were measured in 5 CSS (Bann et al., 2015; Santos
et al., 2012; Sardinha et al., 2015; Lee et al., 2015; Larsen et al.,
2014a). 4 CSS also evaluated the association of SB and some perfor-
mance biomarkers. Lee et al. (2015) found a statistically signiﬁcant
negative correlation for SB with gait speed and chair stand rate.
Santos et al. (2012) constructed a composite Z-score of 6 perfor-
mance biomarkers (6 min  walk test, 8 foot up and go, arm curl,
chair stand rate, chair sit and reach or back scratch) which associa-
tion with SB was signiﬁcant negative, but he did not list the results
separately. Bann et al. (2015) and Sardinha et al. (2015) did not ﬁnd
a signiﬁcant correlation for SB and performance biomarkers.
3.6.5. SB and inﬂammatory biomarkers
There was a relative paucity of studies investigating inﬂamma-
tory biomarkers and SB. CRP was investigated most frequently,
although restricted to 4 CSS studies and 1 RCT, with only 2 CSS
studies demonstrating that SB was positively associated with CRP.
Only 2 CSS studies investigated IL-6 and SB, with 1 CSS ﬁnding a
positive association. Given the limited number of studies and over
reliance on CSS, the evidence base is inconclusive concerning the
relationship between SB and inﬂammatory markers.
3.6.6. SB and other biomarkers
There was a distinct lack of studies investigating renal or bone
biomarkers and SB. Only 1 study measured Vitamin D status (Scott
et al., 2015), but it was  considered as too low in quality ((see 9) in
‘Risk of bias appraisal’), because different points of time exposure
and outcome were measured.
Leptin, which can be seen as adiposity-associated inﬂammation
marker or regulation marker of hunger and fat metabolism, was
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higher with a higher amount of time spent sedentary (2 of 4 studies
signiﬁcant, 1 POS).
We  could not identify any study investigating renal, cellular,
respiratory, signal transduction or genetic biomarkers and SB meet-
ing our inclusion criteria. None of the included studies evaluated
the impact of SB on biomarkers of the gastrointestinal or periph-
eral/central nervous system, neither focused on steroid or hormone
biomarkers.
4. Discussion
Within our comprehensive systematic review, ﬁndings from
high quality papers showed mixed evidence for the association
of SB and biomarkers. When statistically signiﬁcant results were
prominent, SB was associated in an unfavourable direction, espe-
cially in anthropometric (BMI, WC,  neck circumference, fat mass),
blood lipid (cholesterol, HDL, LDL), glycaemic (HbA1c, insulin,
HOMA-IR, C-peptide) and hormonal (leptin) biomarkers. However
several statistically non-signiﬁcant study results were detected,
many of which were of high quality. Some results of lower qual-
ity studies may  be incidental ﬁndings or point to the existence of
additional confounders, which are unaccounted so far.
Despite the relative paucity and equivocal nature of SB and
biomarkers in older age, studies performed in younger cohorts
strengthen the hypothesis that SB has harmful effects on biomarker
levels. For instance, Healy et al. (2008a,b) found an inverse relation
of breaks in ST and BMI  (Healy et al., 2008a) and WC  (Healy et al.,
2008a,b) or Zhou et al. (2016) revealed an increased risk for devel-
oping Metabolic Syndrome (MES) with higher ST support those
ﬁndings. Fasting insulin levels, another MES  risk factor, improved
with reducing ST (Aadahl et al., 2014; Cooper et al., 2012). Simi-
lar results for glycaemic biomarkers, such as postprandial glucose
and insulin levels were detected in other RCTs (Duvivier et al.,
2013; Peddie et al., 2013) or CSS (Yates et al., 2012) performed
in younger cohorts. Considering results from Krogh-Madsen et al.
(2010), showing a decrease in insulin-stimulated muscle activity
phosphorylation and decreased peripheral insulin sensitivity by
reducing daily activity for only 2 weeks, there appears to be a
strong connection between SB and impaired glucose and insulin
metabolism in younger age.
Our review identiﬁed some studies that evaluated the associ-
ation between change in ST and systemic parameters, including
blood pressure (Gabriel et al., 2012; Reaven et al., 1991; Jakes et al.,
2003), or heart rate (Reaven et al., 1991). Surprisingly and contrary
to our expectation we  identiﬁed no association between change
of SB with blood pressure in 3 included RCTs (Suboc et al., 2014;
Kirk et al., 2009; Kallings et al., 2009). Investigations in younger
cohorts demonstrated a clear trend of signiﬁcantly improving BP
levels by reducing ST (Christofaro et al., 2015) or by breaking up
prolonged sitting periods (Larsen et al., 2014b). Already the advice
of increasing PA levels seems to have a positive effect coming along
with lower BP levels (Figueira et al., 2014). Possible explanations for
no effects in older cohorts could be confounding by antihyperten-
sive medication, increased arterial stiffness or reduced heart rate
variability (Bonnemeier et al., 2003) in older age. Similar effects
were detected for blood lipids, with better proﬁles associated to
less ST (Marsh et al., 2014). As underlying mechanism Hamilton
et al. (2007, 2004) suggested a poor lipid metabolism with inac-
tivity by suppression of skeletal muscle lipoprotein lipase activity.
SB has also been associated with chronic low-grade inﬂamma-
tion in younger cohorts (Yates et al., 2012; Falconer et al., 2014).
When looking in elderly people we only identiﬁed few, mainly CSS
(Gennuso et al., 2013; Henson et al., 2013; Fung, 2000; Allison et al.,
2012; Hamer et al., 2013), showing higher levels of CRP, IL-6 and
leptin in those with less physical activity. Besides missing longitudi-
nal data a higher low-grade inﬂammation (Franceschi and Campisi,
2014) in older age could distort or reduce the effect size of these
outcomes.
Over and above preserving autonomy in older age is impor-
tant in order to maintain independence and quality of life. Dunlop
et al. (2015) reported a 46% greater odds of ADL  disability
for each hour spent sedentary. Muscle function (Conley et al.,
2013) also appears to be negatively affected by SB suggesting
that macroscopic/performance (Cawthon et al., 2013) and micro-
scopic/biochemical parameters (Conley et al., 2013) would change
depending on ST. The results found for our systematic review were
few. Results from Santos et al. (2012), who constructed a com-
posite Z-score out of different performance biomarkers, suggests
a negative association for performance biomarkers with SB, but no
longitudinal data of performance or muscle biomarkers is available
and thus drawing of causal conclusions is not possible. Given this,
future prospective studies should prioritise functional assessments
like the short physical performance battery (SPPB), grip strength
and dynamic muscle function. Such measures are easy to ascertain
with an evaluated predictive proﬁle and can serve as modiﬁable
surrogates of autonomy in later life.
The highlighted results of the four “risk population” studies
showed associations for SB with biomarkers in the same direc-
tion as the studies performed in non-risk populations. The results
from Lee et al. (2015), performed in the high risk osteoarthri-
tis population with lower gait speed and lower chair stand rate
associated with higher levels of SB can be argued over. This is
the only study, which showed (remaining) statistically signiﬁcant
results for performance parameters. Even if SB measurements were
adjusted for osteoarthritis pain index, osteoarthritis symptoms and
other comorbidity indices, there could be still another unknown
confounder, related to osteoarthritis triggering this biomarker out-
come.
Surprisingly, there was an absence of studies (meeting our inclu-
sion criteria) investigating SB and its possible impact on renal,
muscle or bone biomarkers performed in the elderly. There is
however good reason to believe that especially bone and muscle
metabolism is inﬂuenced from SB due to multifactorial processes.
Prioreschi et al. (2015) results from a smaller cohort revealed low
bone mass for higher levels of SB and a possible protective effect for
bone mineral density with breaking up ST more frequently. Even
in younger cohorts, ST has been implicated as being negatively
related to changes in whole-body bone mineral density, lumbar
spine bone mineral content, lumbar spine bone area and femoral
neck (Ivusˇka¯ns et al., 2015).
A large number of studies were excluded from our review
because they speciﬁcally measured PA rather than focus on the dis-
tinct construct of SB. For instance, several studies focussed on a lack
of PA rather than SB (Kirk et al., 2009; Kallings et al., 2009). Recently
there is a rising interest of SB consequences and the idea of clearly
differentiating between the distinct behaviours of SB and PA. In this
direction, Barone Gibbs et al. (2016) demonstrated a higher effec-
tiveness for improving the SPPB score by reducing SB compared
to increasing moderate to vigorous PA. For that reason, biomark-
ers should be evaluated for both, PA and SB. Former investigations
have shown that SB effects on biomarkers are independently of
MVPA levels (Cooper et al., 2014; Healy et al., 2008b; Yates et al.,
2012). Additionally reducing inactivity often has a higher effective-
ness on the biomarker level, than the amount of physical activity
itself (Duvivier et al., 2013; Peddie et al., 2013). For that reason
new studies should investigate biomarkers and health outcomes
with focusing on reducing SB.
Whilst our comprehensive review provides novel insights, some
limitations should be mentioned. First, we identiﬁed relatively few
high quality or longitudinal studies investigating SB and biomark-
ers speciﬁcally in older adults. Therefore, we were not able to
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conduct a meta-analysis as we anticipated. Additionally the CADTH
tool (CADTH, 2016), used for standardised statements about the
statistical signiﬁcance, was adapted, so we were able to apply it
to fewer studies available. This should be considered, when rat-
ing the state of evidence. Second, there were no stratiﬁed analyses
assessing the question if age or gender is a possible effect mod-
iﬁer. Both, age and gender were often added into the analysis as
confounders, but there is still the necessity to evaluate the possi-
ble presence of interaction in the association between sedentary
behaviour and different biomarkers. Third there was  consider-
able heterogeneity in the deﬁnitions of SB and the high diversity
of reported outcome-parameters, again a pertinent factor making
meta-analysis impossible. SB was often misclassiﬁed as simply a
lack of PA. With respect to the performed analyses some stud-
ies measured the mean change (Bann et al., 2015; Kallings et al.,
2009), others calculated odds ratios (Gao et al., 2007) or Pearson
correlation coefﬁcients (Gabriel et al., 2012), whereas others calcu-
lated a linear or multiple regression coefﬁcient (Henson et al., 2013;
Cooper et al., 2014; Allison et al., 2012). Strict deﬁnitions focussing
speciﬁcally on SB are necessary to allow comparison of results from
different studies. There are currently several initiatives attempting
to harmonize these approaches such as the standardised deﬁ-
nition of SB published in 2012 (Sedentary Behaviour Research
Network, 2012), the 2011 launched online “Sedentary Behaviour
Research Network” (SBRN) (SBRN, 2016) or the SIT project from
Chastin and Skelton (in press). There are some initiatives aimed
tackling SB. A large Canadian organization called ParticipACTION
(ParticipACTION, 2016) is trying to help Canadians to sit less by
offering age adjusted activity programs. Similar intentions are
given in the multi-centre EU study SITLESS (SITLESS, 2016) with
the aim of reducing SB in elderly by a PA intervention enhanced
by self-management-strategies. Objectively measured SB will be
correlated with several biomarkers and muscle biopsy results to
further elucidate the biochemical inﬂuence of SB on health out-
comes.
Currently, we have limited understanding of the impact of SB
on different biomarker systems in older age. The current knowl-
edge base in this regard is overwhelmingly based upon CSS. Given
our ﬁndings, there is an urgent need for adequately representative,
prospective cohort and randomized controlled studies to investi-
gate the impact of SB on various biomarkers in order to ascertain
a better understanding of the pathophysiological and also to test
the hypothesis for causality. Besides the majority of studies were
of moderate to high quality, the presence of reporting bias should
still be considered. Some effects of selection bias could be present as
well, regarding that some studies focused on participants of a high
risk population, such as diabetes mellitus patients (Cooper et al.,
2012, 2014) or breast cancer survivors (Lynch et al., 2010). Addi-
tionally 17 of our 26 studies calculated SB by subjective methods,
which are less accurate than objective methods, since people tend
to underestimate their time spend in SB, due to simple uncertainty
or social desirability (Harvey et al., 2013). In future research objec-
tively measured SB should be preferred to better calculate the real
time spent sedentary.
5. Conclusion
There is a paucity of studies investigating the impact of seden-
tariness in older people. Currently there is mixed evidence for the
impact of SB and biomarkers. When statistically signiﬁcant results
were found, SB was associated in an unfavourable way  to biomark-
ers, but results were mostly derived from cross sectional studies
and thus should be interpreted accordingly. Due to a broad deﬁni-
tion and misclassiﬁcation of sedentary behaviour as simple lack of
physical activity there is still a deﬁciency of evident, causal rela-
tions. There is a need for high quality studies to better understand
the underlying pathophysiological pathways and ﬁnally the bur-
den between sedentary behaviour and the biomarkers implicated.
Broad investigations are necessary to evaluate possible impact
of sedentary behaviour on biomarkers, including those with an
absence of data such as bone and muscles biomarkers. Future
research should utilise an ofﬁcial deﬁnition of sedentary behaviour,
clearly disentangle the relationships between each biomarker and
sedentary behaviour and physical activity and use objective or at
the least use standardised self-report measures for assessing seden-
tary time.
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Appendix A.
Table A1
Table A1
Search strategy.
concepts search terms
sedentariness seden* OR television OR accelerometer OR pedometer
age age OR aging OR elderly OR older
biomarkers bone biomarker OR biomarker OR CRP OR interleukin OR
endocrine OR diabetes OR insulin OR cardiovascular OR CNS
OR central nervous system OR neurological OR  hormones OR
inﬂammation OR hematology OR blood OR liquor OR
epigenetic OR genetic OR DNA OR RNA or ultrasound OR BIA or
bioelectrical OR caliper OR stem cell OR cerebrovascular OR
cancer OR cytokine OR mitochondr* OR immune OR protein
OR urine OR muscle OR gait OR factor OR transcription OR
strength OR handgrip OR oncology OR nephrology OR  men
health OR women health OR COPD OR pulmonary OR  lung OR
asthma OR glucose OR GID OR gastrointestinal OR gastric OR
lipoprotein OR anabol OR katabol OR thyroid OR steroid OR
metabolic OR testosterone OR estrogen
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Appendix B.
Table A2
Table A2
Deﬁnitions.
Accelerometer An instrument for measuring the acceleration
of  a moving body
Biomarker A characteristic that is objectively measured
and evaluated as an indicator of normal
biological processes, pathogenic processes, or
pharmacologic responses to a therapeutic
intervention
Moderate-vigorous physical
activity
Physical activity performed at intensity ≥3
Metabolic Equivalents (METs)
Sedentary behaviour Activities with an energy expenditure ≤ 1.5
Metabolic Equivalents (METs) while in a sitting
or reclining posture during waking hours; not
simply the absence of physical activity
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